FDA Investigator: Michael R. Klapal

- Michael R. Klapal first started conducting FDA inspections in 2008, with the last inspection in 2019. Over that time, Michael R. Klapal has conducted 118 inspections at 85 companies across 93 sites.

Get Michael Klapal's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 KVK-Tech, Inc., Newtown | 2019

Out-of-stock
Michael R. Klapal
Human Drug Form 483

FDA 483 Vetter Pharma Fertigung GmbH & Co. KG, Ravensburg | 2018

Out-of-stock
Michael R. Klapal
Human Drug Form 483

FDA 483 KVK-Tech, Inc., Newtown | 2017

Out-of-stock
Michael R. Klapal
Human Drug Form 483

FDA 483 Ferring Production, Parsippany | 2016

Out-of-stock
Michael R. Klapal
Human Drug Form 483

FDA 483 Pharmacy Creations, Randolph | 2015

Out-of-stock
Michael R. Klapal
Human Drug Form 483

FDA 483 Halo Pharmaceutical, Inc., Whippany | 2015

Out-of-stock
Michael R. Klapal
Human Drug Form 483

FDA 483 Hospira Healthcare India Pvt Ltd, Parawada Mandal, Visakhapatnam | 2015

Out-of-stock
Michael R. Klapal
Human Drug Form 483

FDA 483 Hospira Healthcare India Pvt Ltd, Parawada Mandal, Visakhapatnam | 2015

Out-of-stock
Michael R. Klapal
Human Drug Form 483

FDA 483 RiconPharma LLC, Denville | 2015

Out-of-stock
Michael R. Klapal
Human Drug Form 483

Co-Investigators (48)